27 June 2016: Awarded British Council-Ungku Omar Fund Dengue Tech Challenge grant for the clinical development of RetroMAD1 by HRH Duke of York, Prince Andrew.
5 Apr 2014: Presentation at Malaysian Fisheries Society (MFS) on Early Mortality Syndrome (EMS) Mechanism of Bacterial Infection, University Putra Malaysia, Serdang.
24-25 Jan 2014: CTO presented on White Spot Syndrome Virus (WSSV) and Early Mortality Syndrome (EMS) – The Way Forward, in the 7th Aqua India, Vijayawada, India.
17-20 Dec 2013: CTO presented in the Asia-Pacific Congress of Virology in Amity University, New Dehli, India.
9-13 Dec 2013: CTO presented at the World Aquaculture Society Asia-Pacific Chapter meetings in Vietnam.
30 Nov 2013: Biovalence co-organised a one-day workshop on Early Mortality Syndrome (EMS) together with the Malaysian Society of Marine Science.
24-25 Oct 2013: CTO attended and presented poster at 8th Annual Peptide Therapeutics Symposium at the Salk Institute La Jolla, San Diego.
4-6 Sept 2013: CTO, Mr. Ung Eng Huan presented and attended the APEC Conference on Biotechnology Commercialization organised by the Malaysian Biotechnology Corporation.
19-20 Mar 2013: Exhibited at the 6th Annual BioPharma Asia 2013, Singapore. Mr. Ung Eng Huan, CTO of BioValence presented on “RetroMAD1 ‘First-in-Class’ Broad-spectrum Oral Delivery Antiviral Protein”
10 Aug 2012: Received NPCB approval to build cGMP Facility for Phase I Clinical Batch Production.